Qian‐Ru Du

426 total citations
11 papers, 373 citations indexed

About

Qian‐Ru Du is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Qian‐Ru Du has authored 11 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Qian‐Ru Du's work include HER2/EGFR in Cancer Research (4 papers), Quinazolinone synthesis and applications (4 papers) and Microbial Natural Products and Biosynthesis (2 papers). Qian‐Ru Du is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Quinazolinone synthesis and applications (4 papers) and Microbial Natural Products and Biosynthesis (2 papers). Qian‐Ru Du collaborates with scholars based in China. Qian‐Ru Du's co-authors include Hai‐Liang Zhu, Dong‐Dong Li, Fei Fang, Hai‐Bin Gong, Yong Qian, Jian Sun, Jian Sun, Weiqing Zhong, Yichuan Deng and Jack C.P. Cheng and has published in prestigious journals such as PLoS ONE, Sensors and Actuators B Chemical and RSC Advances.

In The Last Decade

Qian‐Ru Du

11 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qian‐Ru Du China 10 233 109 56 37 37 11 373
Lena Ripa Sweden 12 210 0.9× 127 1.2× 27 0.5× 22 0.6× 8 0.2× 16 359
Gregory B. Craven United Kingdom 10 195 0.8× 262 2.4× 57 1.0× 17 0.5× 12 0.3× 17 397
Goss S. Kauffman United States 11 384 1.6× 216 2.0× 34 0.6× 21 0.6× 36 1.0× 15 528
Ricardo A. M. Serafim Brazil 12 332 1.4× 188 1.7× 46 0.8× 9 0.2× 18 0.5× 21 539
B. Mamat Germany 6 42 0.2× 139 1.3× 17 0.3× 12 0.3× 9 0.2× 7 293
Scott R. Pollack United States 9 189 0.8× 98 0.9× 47 0.8× 11 0.3× 31 0.8× 16 299
Kristen L. Arienti United States 8 117 0.5× 210 1.9× 82 1.5× 21 0.6× 9 0.2× 8 364
Matthew E. Cuellar United States 9 84 0.4× 255 2.3× 18 0.3× 37 1.0× 26 0.7× 14 356
Karl J. Okolotowicz United States 13 102 0.4× 164 1.5× 45 0.8× 24 0.6× 9 0.2× 20 337
Hamilton D. Dickson United States 11 217 0.9× 171 1.6× 68 1.2× 11 0.3× 20 0.5× 13 378

Countries citing papers authored by Qian‐Ru Du

Since Specialization
Citations

This map shows the geographic impact of Qian‐Ru Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian‐Ru Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian‐Ru Du more than expected).

Fields of papers citing papers by Qian‐Ru Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qian‐Ru Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian‐Ru Du. The network helps show where Qian‐Ru Du may publish in the future.

Co-authorship network of co-authors of Qian‐Ru Du

This figure shows the co-authorship network connecting the top 25 collaborators of Qian‐Ru Du. A scholar is included among the top collaborators of Qian‐Ru Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qian‐Ru Du. Qian‐Ru Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Dong‐Dong, Jian Sun, Fei Fang, et al.. (2013). Optimization of Substituted 6-Salicyl-4-Anilinoquinazoline Derivatives as Dual EGFR/HER2 Tyrosine Kinase Inhibitors. PLoS ONE. 8(8). e69427–e69427. 20 indexed citations
2.
Li, Dong‐Dong, Fei Fang, Qian‐Ru Du, et al.. (2013). Discovery of 4,6-substituted-(diaphenylamino)quinazolines as potent c-Src inhibitors. Organic & Biomolecular Chemistry. 11(48). 8375–8375. 12 indexed citations
3.
Sun, Jian, Dong‐Dong Li, Fei Fang, et al.. (2013). Design, synthesis, biological evaluation, and molecular modeling study of 4-alkoxyquinazoline derivatives as potential VEGFR2 kinase inhibitors. Organic & Biomolecular Chemistry. 11(44). 7676–7676. 26 indexed citations
4.
Sun, Jian, Xianhai Lv, Han‐Yue Qiu, et al.. (2013). Synthesis, biological evaluation and molecular docking studies of pyrazole derivatives coupling with a thiourea moiety as novel CDKs inhibitors. European Journal of Medicinal Chemistry. 68. 1–9. 52 indexed citations
5.
Zhou, Yang, Qian‐Ru Du, Jian Sun, et al.. (2013). Novel Schiff‐Base‐Derived FabH Inhibitors with Dioxygenated Rings as Antibiotic Agents. ChemMedChem. 8(3). 433–441. 11 indexed citations
6.
Li, Dong‐Dong, Rongrong Wang, Jian Sun, et al.. (2013). Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity. European Journal of Medicinal Chemistry. 75. 438–447. 38 indexed citations
7.
Du, Qian‐Ru, Dong‐Dong Li, Fei Fang, et al.. (2013). Novel 1,3,4-oxadiazole thioether derivatives targeting thymidylate synthase as dual anticancer/antimicrobial agents. Bioorganic & Medicinal Chemistry. 21(8). 2286–2297. 101 indexed citations
8.
Cheng, Jack C.P., Yichuan Deng, & Qian‐Ru Du. (2013). Mapping between BIM models and 3d GIS city models of different levels of detail. 26 indexed citations
9.
Fang, Fei, Dong‐Dong Li, Jian Sun, et al.. (2013). Design, synthesis, and evaluation of substituted 6-amide-4-anilinoquinazoline derivatives as c-Src inhibitors. RSC Advances. 3(48). 26230–26230. 7 indexed citations
10.
Qian, Yong, Bingya Yang, Yuning Shen, et al.. (2013). A BODIPY–coumarin-based selective fluorescent probe for rapidly detecting hydrogen sulfide in blood plasma and living cells. Sensors and Actuators B Chemical. 182. 498–503. 45 indexed citations
11.
Li, Dong‐Dong, Fei Fang, Qian‐Ru Du, et al.. (2012). Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(18). 5870–5875. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026